HypnoVR’s move on Oncomfort will strengthen its hold on the digital therapies market, give it a bigger foothold in Belgium and expand its product range by incorporating Oncomfort’s solution - HypnoVR has been working on its own system offering a real-time virtual hypnosedation session.
With over 550 European healthcare facilities on its books, over 200,000 patients have already been treated by HypnoVR’s digital therapies, helping them deal with pain management, and anxiety, reducing the amount of medication used.
“The Oncomfort acquisition is a highly strategic step for HypnoVR that reinforces our position as the European leader in digital therapies to treat pain and anxiety and provides an ever-increasing number of healthcare facilities and patients with access to these advanced technologies. Our vision is one that Oncomfort shares, based on the clinical validity of digital therapeutic solutions and the potential of technology to deliver them to as many people as possible. HypnoVR pioneered the development and roll-out of virtual reality-based medical hypnosis solutions in France and Europe, and we intend to ramp up this work on an international scale,” says Nicolas Schaettel, president and co-founder of HypnoVR.
“Both HypnoVR and Oncomfort are pioneering companies in digital sedation and have been built on shared values, scientific validation and strict adherence to regulations to ensure compliance with the requirements for digital medical devices. I firmly believe that our acquisition by HypnoVR will create worthwhile collaborations to help healthcare professionals go further in adopting this solution as the standard of care for relieving pain and anxiety, benefiting a growing number of patients,” says Diane Jooris, founder of Oncomfort.
Lead image: HypnoVR headset Photo: HypnoVR.